Pharming Group N.V. - ADR
NASDAQ:PHAR 1:24:26 PM EDT
| Market Cap (Intraday) | 777.82M |
| Current PE | 25.61 |
| Forward PE | 27.14 |
| 2yr Forward PE | 42.64 |
| 10-Day MA | $12.29 |
| 50-Day MA | $10.88 |
| 200-Day MA | $9.46 |
Pharming Group N.V. - ADR Stock, NASDAQ:PHAR
Darwinweg 24, Leiden, Zuid-Holland 2332 CR
Netherlands
Phone: +31.71.524.74.00
Number of Employees:
Description
Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following geographical segments: the United States, Europe, and Rest of the World. The company was founded on November 11, 1988 and is headquartered in Leiden, the Netherlands.